UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034584
Receipt number R000039423
Scientific Title Effects of vestibular stimulation on subjective visual vertical in healthy subjects
Date of disclosure of the study information 2018/10/21
Last modified on 2022/10/27 18:53:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of vestibular stimulation on subjective visual vertical in healthy subjects

Acronym

Effects of vestibular stimulation on subjective visual vertical in healthy subjects

Scientific Title

Effects of vestibular stimulation on subjective visual vertical in healthy subjects

Scientific Title:Acronym

Effects of vestibular stimulation on subjective visual vertical in healthy subjects

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To survey how subjective visual vertical of healthy subjects change when they undergo galvanic vestibular stimulation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The difference of subjective visual vertical before the vestibular stimulation and during the stimulation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Right anode galvanic vestibular stimulation will be done for 3minutes by placing the electrode on both side of mastoid process with low amplitude (1.5mA) direct electric current

Interventions/Control_2

Light anode galvanic vestibular stimulation will be done for 3minutes by placing the electrode on both side of mastoid process with low amplitude (1.5mA) direct electric current

Interventions/Control_3

Sham stimulation will be done for 3minutes by placing the electrode on both side of mastoid process with low amplitude (1.5mA) direct electric current

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy subjects who shows decision by themselves to participate in the study, and who can understand the details and risk of the study by using the instruction and letter of consent

Key exclusion criteria

Who has pacemaker or VP-shunt etc. in their body, who cannot sit without handrail, who suffers from neurological disease, who is being treated of otorhinological disease which may be related to the vestibular nerve, who has a experience of epileptic seizure, who is being treated of head injury

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Tomioka

Organization

National Hospital Organization Murayama Medical Center

Division name

Department of Rehabilitation

Zip code

2080011

Address

2-37-1 Gakuen, Musashimurayama City, Tokyo

TEL

042-561-1221

Email

ytomi@keio.jp


Public contact

Name of contact person

1st name Yohei
Middle name
Last name Tomioka

Organization

National Hospital Organization Murayama Medical Center

Division name

Department of Rehabilitation

Zip code

2080011

Address

2-37-1 Gakuen, Musashimurayama City, Tokyo

TEL

042-561-1221

Homepage URL


Email

ytomi@keio.jp


Sponsor or person

Institute

National Hospital Organization Murayama Medical Center Clinical Research Center

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Murayama Medical Center Clinical Research Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tokyo Bay Rehabilitation Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Murayama Medical Center Clinical Research Center

Address

2-37-1 Gakuen, Musashimurayama City, Tokyo

Tel

042-561-1496

Email

rinken@murayama-crc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 01 Day

Date of IRB

2018 Year 07 Month 26 Day

Anticipated trial start date

2018 Year 08 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 21 Day

Last modified on

2022 Year 10 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039423


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name